发明申请
- 专利标题： GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE
- 专利标题（中）： 糖苷相互作用化合物和使用方法
-
申请号： PCT/US2016/061427申请日： 2016-11-10
-
公开(公告)号： WO2017083582A1公开(公告)日： 2017-05-18
- 发明人: EAVARONE, David A. , PRENDERGAST, Jillian M. , BEHRENS, Jeffrey , LUGOVSKOY, Alexey Alexandrovich , DRANSFIELD, Daniel T.
- 申请人： SIAMAB THERAPEUTICS, INC.
- 申请人地址： 90 Bridge Street Suite 100 Newton, Massachusetts 02458 US
- 专利权人： SIAMAB THERAPEUTICS, INC.
- 当前专利权人： SIAMAB THERAPEUTICS, INC.
- 当前专利权人地址： 90 Bridge Street Suite 100 Newton, Massachusetts 02458 US
- 代理机构： WARD, Donna T. et al.
- 优先权： US62/254,278 20151112; US62/274,572 20160104; US62/287,666 20160127; US62/293,989 20160211; US62/345,515 20160603; US62/382,835 20160902
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/00 ; C07K16/30 ; G01N33/574
摘要：
The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include humanized antibodies, derivatives and fragments thereof as well as related compositions and kits. Methods of using glycan-interacting antibodies for treatment and diagnosis are included.
